Nuvalent Stock Alpha and Beta Analysis
| NUVL Stock | USD 87.75 2.23 2.61% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Nuvalent. It also helps investors analyze the systematic and unsystematic risks associated with investing in Nuvalent over a specified time horizon. Remember, high Nuvalent's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Nuvalent's market risk premium analysis include:
Beta 0.87 | Alpha (0.16) | Risk 2.48 | Sharpe Ratio (0) | Expected Return (0) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Nuvalent |
Nuvalent Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Nuvalent market risk premium is the additional return an investor will receive from holding Nuvalent long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Nuvalent. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Nuvalent's performance over market.| α | -0.16 | β | 0.87 |
Nuvalent expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Nuvalent's Buy-and-hold return. Our buy-and-hold chart shows how Nuvalent performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Nuvalent Market Price Analysis
Market price analysis indicators help investors to evaluate how Nuvalent stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Nuvalent shares will generate the highest return on investment. By understating and applying Nuvalent stock market price indicators, traders can identify Nuvalent position entry and exit signals to maximize returns.
Nuvalent Return and Market Media
The median price of Nuvalent for the period between Sat, Nov 2, 2024 and Fri, Jan 31, 2025 is 88.1 with a coefficient of variation of 7.69. The daily time series for the period is distributed with a sample standard deviation of 6.7, arithmetic mean of 87.11, and mean deviation of 5.73. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Disposition of 100 shares by Balcom Alexandra of Nuvalent at 90.94 subject to Rule 16b-3 | 10/31/2024 |
2 | Disposition of 5000 shares by Darlene Noci of Nuvalent at 14.4 subject to Rule 16b-3 | 11/01/2024 |
3 | Disposition of tradable shares by Shair Matthew of Nuvalent at 97.4 subject to Rule 16b-3 | 11/25/2024 |
4 | Disposition of 1858 shares by Balcom Alexandra of Nuvalent at 96.25 subject to Rule 16b-3 | 11/29/2024 |
5 | Nuvalent appoints new independent director | 12/09/2024 |
6 | Disposition of 1250000 shares by Hack Andrew A. F. of Nuvalent at 88.0 subject to Rule 16b-3 | 12/11/2024 |
7 | Disposition of 8031 shares by James Porter of Nuvalent at 86.96 subject to Rule 16b-3 | 12/16/2024 |
8 | Acquisition by Balcom Alexandra of 4728 shares of Nuvalent at 1.08 subject to Rule 16b-3 | 12/17/2024 |
9 | Nuvalent Inc to Present at J.P. Morgan Healthcare Conference | 12/19/2024 |
10 | Disposition of 591 shares by Shair Matthew of Nuvalent at 84.17 subject to Rule 16b-3 | 12/23/2024 |
11 | This American Airlines Analyst Turns Bullish Here Are Top 3 Upgrades For Monday | 12/30/2024 |
12 | Acquisition by James Porter of 112500 shares of Nuvalent at 78.09 subject to Rule 16b-3 | 01/06/2025 |
13 | Acquisition by Turner Christopher Durant of 18750 shares of Nuvalent subject to Rule 16b-3 | 01/08/2025 |
14 | Disposition of 2513 shares by Darlene Noci of Nuvalent at 88.79 subject to Rule 16b-3 | 01/10/2025 |
15 | Nuvalent Inc Outlines Strategic Milestones for 2025 | 01/13/2025 |
16 | Nuvalent Announces Corporate Updates and Anticipated Milestones for 2025 | 01/14/2025 |
17 | Nuvalents SWOT analysis biotech stock shows promise amid clinical progress | 01/17/2025 |
18 | Disposition of 108 shares by Shair Matthew of Nuvalent at 85.0 subject to Rule 16b-3 | 01/27/2025 |
19 | Nuvalent director Matthew Shair sells shares worth 165,575 - MSN | 01/30/2025 |
About Nuvalent Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Nuvalent or other stocks. Alpha measures the amount that position in Nuvalent has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Nuvalent Upcoming Company Events
As portrayed in its financial statements, the presentation of Nuvalent's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Nuvalent's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Nuvalent's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Nuvalent. Please utilize our Beneish M Score to check the likelihood of Nuvalent's management manipulating its earnings.
| 21st of March 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 21st of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Nuvalent
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Nuvalent Backtesting, Nuvalent Valuation, Nuvalent Correlation, Nuvalent Hype Analysis, Nuvalent Volatility, Nuvalent History and analyze Nuvalent Performance. For more information on how to buy Nuvalent Stock please use our How to buy in Nuvalent Stock guide.You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Nuvalent technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.